Stanniocalcin 2 expression is associated with a favourable outcome in male breast cancer
dc.contributor.author | Coulson-Gilmer, C | |
dc.contributor.author | Humphries, M P | |
dc.contributor.author | Sundara Rajan, S | |
dc.contributor.author | Droop, A | |
dc.contributor.author | Jackson, S | |
dc.contributor.author | Condon, A | |
dc.contributor.author | Cserni, G | |
dc.contributor.author | Jordan, L B | |
dc.contributor.author | Jones, J L | |
dc.contributor.author | Kanthan, R | |
dc.contributor.author | Di Benedetto, A | |
dc.contributor.author | Mottolese, M | |
dc.contributor.author | Provenzano, E | |
dc.contributor.author | Kulka, J | |
dc.contributor.author | Shaaban, A M | |
dc.contributor.author | Hanby, A M | |
dc.contributor.author | Speirs, V | |
dc.date.accessioned | 2018-08-31T09:18:06Z | |
dc.date.available | 2018-08-31T09:18:06Z | |
dc.date.issued | 2018-10 | |
dc.identifier.citation | Coulson-Gilmer , C , Humphries , M P , Sundara Rajan , S , Droop , A , Jackson , S , Condon , A , Cserni , G , Jordan , L B , Jones , J L , Kanthan , R , Di Benedetto , A , Mottolese , M , Provenzano , E , Kulka , J , Shaaban , A M , Hanby , A M & Speirs , V 2018 , ' Stanniocalcin 2 expression is associated with a favourable outcome in male breast cancer ' , The Journal of Pathology. Clinical Research , vol. 4 , no. 4 , pp. 241-249 . https://doi.org/10.1002/cjp2.106 | en |
dc.identifier.issn | 2056-4538 | |
dc.identifier.other | PURE: 129545803 | |
dc.identifier.other | PURE UUID: e5244fd1-89cc-41c2-9482-5b366211a4e6 | |
dc.identifier.other | PubMed: 29956502 | |
dc.identifier.other | ORCID: /0000-0002-0602-4666/work/72631271 | |
dc.identifier.other | Scopus: 85054428947 | |
dc.identifier.uri | http://hdl.handle.net/2164/11025 | |
dc.description | Funding Information Breast Cancer Now. Grant Number: TBLEE2017 Yorkshire Cancer Research. Grant Number: L378 | en |
dc.format.extent | 9 | |
dc.language.iso | eng | |
dc.relation.ispartof | The Journal of Pathology. Clinical Research | en |
dc.rights | © 2018 The Authors. The Journal of Pathology: Clinical Research published by The Pathological Society of Great Britain and Ireland and John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. https://creativecommons.org/licenses/by-nc/4.0/ | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | Journal Article | en |
dc.subject | male breast cancer | en |
dc.subject | stanniocalcin 2 | en |
dc.subject | immunochemistry | en |
dc.subject | survival | en |
dc.subject | RB Pathology | en |
dc.subject.lcc | RB | en |
dc.title | Stanniocalcin 2 expression is associated with a favourable outcome in male breast cancer | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Publisher PDF | en |
dc.identifier.doi | https://doi.org/10.1002/cjp2.106 | |
dc.identifier.vol | 4 | en |
dc.identifier.iss | 4 | en |